Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Yoking OX40 to regulation of IL-9.

Goswami R, Kaplan MH.

Nat Immunol. 2012 Oct;13(10):942-3. doi: 10.1038/ni.2421. No abstract available.

PMID:
22990899
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

OX40 signaling favors the induction of T(H)9 cells and airway inflammation.

Xiao X, Balasubramanian S, Liu W, Chu X, Wang H, Taparowsky EJ, Fu YX, Choi Y, Walsh MC, Li XC.

Nat Immunol. 2012 Oct;13(10):981-90. doi: 10.1038/ni.2390. Epub 2012 Jul 29.

PMID:
22842344
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

OX40 (CD134) and OX40L.

Gough MJ, Weinberg AD.

Adv Exp Med Biol. 2009;647:94-107. doi: 10.1007/978-0-387-89520-8_6. Review.

PMID:
19760068
[PubMed - indexed for MEDLINE]
4.

OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.

Goulding J, Tahiliani V, Salek-Ardakani S.

Immunol Rev. 2011 Nov;244(1):149-68. doi: 10.1111/j.1600-065X.2011.01062.x. Review.

PMID:
22017437
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.

Yan J, Su H, Xu L, Wang C.

PLoS One. 2013 Apr 9;8(4):e60854. doi: 10.1371/journal.pone.0060854. Print 2013.

PMID:
23593329
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Airway wall expression of OX40/OX40L and interleukin-4 in asthma.

Siddiqui S, Mistry V, Doe C, Stinson S, Foster M, Brightling C.

Chest. 2010 Apr;137(4):797-804. doi: 10.1378/chest.09-1839. Epub 2010 Feb 5.

PMID:
20139223
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.

Kondo K, Okuma K, Tanaka R, Zhang LF, Kodama A, Takahashi Y, Yamamoto N, Ansari AA, Tanaka Y.

Hum Immunol. 2007 Jul;68(7):563-71. Epub 2007 Apr 13.

PMID:
17584577
[PubMed - indexed for MEDLINE]
8.

OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.

Ishii N, Takahashi T, Soroosh P, Sugamura K.

Adv Immunol. 2010;105:63-98. doi: 10.1016/S0065-2776(10)05003-0. Review.

PMID:
20510730
[PubMed - indexed for MEDLINE]
9.

Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.

van Wanrooij EJ, van Puijvelde GH, de Vos P, Yagita H, van Berkel TJ, Kuiper J.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):204-10. Epub 2006 Oct 26.

PMID:
17068285
[PubMed - indexed for MEDLINE]
Free Article
10.

OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.

Xiao X, Kroemer A, Gao W, Ishii N, Demirci G, Li XC.

J Immunol. 2008 Sep 1;181(5):3193-201.

PMID:
18713990
[PubMed - indexed for MEDLINE]
Free Article
11.

Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.

Redmond WL, Weinberg AD.

Crit Rev Immunol. 2007;27(5):415-36. Review.

PMID:
18197805
[PubMed - indexed for MEDLINE]
12.

OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.

Kim MY, Anderson G, White A, Jenkinson E, Arlt W, Martensson IL, Erlandsson L, Lane PJ.

J Immunol. 2005 Jun 1;174(11):6686-91.

PMID:
15905508
[PubMed - indexed for MEDLINE]
Free Article
13.

Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

Xie F, Wang Q, Chen Y, Gu Y, Mao H, Zeng W, Zhang X.

Pathol Res Pract. 2010 Nov 15;206(11):735-9. doi: 10.1016/j.prp.2010.05.016. Epub 2010 Jul 15.

PMID:
20634005
[PubMed - indexed for MEDLINE]
14.

Blockade of OX40/OX40 ligand to decrease cytokine messenger RNA expression in acute renal allograft rejection in vitro.

Wang YL, Li G, Fu YX, Wang H, Shen ZY.

Transplant Proc. 2013 Jul-Aug;45(6):2565-8. doi: 10.1016/j.transproceed.2013.03.038.

PMID:
23953582
[PubMed - indexed for MEDLINE]
15.

Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation.

Vogel KU, Edelmann SL, Jeltsch KM, Bertossi A, Heger K, Heinz GA, Zöller J, Warth SC, Hoefig KP, Lohs C, Neff F, Kremmer E, Schick J, Repsilber D, Geerlof A, Blum H, Wurst W, Heikenwälder M, Schmidt-Supprian M, Heissmeyer V.

Immunity. 2013 Apr 18;38(4):655-68. doi: 10.1016/j.immuni.2012.12.004. Epub 2013 Apr 11.

PMID:
23583643
[PubMed - indexed for MEDLINE]
Free Article
16.

OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity.

Ilves T, Harvima IT.

J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e197-205. doi: 10.1111/j.1468-3083.2012.04587.x. Epub 2012 May 31.

PMID:
22646697
[PubMed - indexed for MEDLINE]
17.

Co-stimulatory molecule OX40 ligand in early human pregnancy.

Yoshimatsu J, Matsumoto H, Narahara H.

Int J Gynaecol Obstet. 2006 Jun;93(3):240-1. Epub 2006 Apr 12. No abstract available.

PMID:
16626714
[PubMed - indexed for MEDLINE]
18.

Negative regulation of IL-17 production by OX40/OX40L interaction.

Li J, Li L, Shang X, Benson J, Merle Elloso M, Schantz A, Bracht M, Orlovsky Y, Sweet R.

Cell Immunol. 2008 May-Jun;253(1-2):31-7. doi: 10.1016/j.cellimm.2008.04.010. Epub 2008 May 23.

PMID:
18501882
[PubMed - indexed for MEDLINE]
19.

Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40.

Pratico ED, Sullenger BA, Nair SK.

Nucleic Acid Ther. 2013 Feb;23(1):35-43. doi: 10.1089/nat.2012.0388. Epub 2012 Oct 31.

PMID:
23113766
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

OX40-OX40 ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells.

Yan J, Wang C, Du R, Liu P, Chen G.

Chem Biol Interact. 2009 Aug 14;180(3):460-4. doi: 10.1016/j.cbi.2009.04.009. Epub 2009 May 3.

PMID:
19416722
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk